147 related articles for article (PubMed ID: 17094561)
1. [Initial efficacy of intramuscular injection of botulinum toxin type A against cervical dystonia and general muscular hypertonia in persons with severe motor and intellectual disabilities].
Adachi M; Saura R
No To Hattatsu; 2006 Nov; 38(6):425-30. PubMed ID: 17094561
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of botulinum toxin type A against cervical dystonia and muscular hypertonia in persons with severe motor and intellectual disabilities with respiratory problems and/or dysphagia].
Yokoyama M; Honda M; Okoshi Y; Masuyama T; Iwasaki Y; Arima M
No To Hattatsu; 2011 Jul; 43(4):273-6. PubMed ID: 21800689
[TBL] [Abstract][Full Text] [Related]
3. [Effects of botulinum toxin therapy for respiratory distress in patients with cervical hypertonia].
Hashimoto N; Kagitani-Shimono K; Tominaga K; Kitai Y; Ikeda T; Okinaga T; Taniike M; Ozone K
No To Hattatsu; 2012 Jan; 44(1):13-8. PubMed ID: 22352024
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hyperfunctional lines of the face with botulinum toxin A.
Binder WJ; Blitzer A; Brin MF
Dermatol Surg; 1998 Nov; 24(11):1198-205. PubMed ID: 9834739
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.
Tan EK; Jankovic J
Neurology; 1999 Dec; 53(9):2102-7. PubMed ID: 10599789
[TBL] [Abstract][Full Text] [Related]
6. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
[TBL] [Abstract][Full Text] [Related]
7. Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia.
Ansved T; Odergren T; Borg K
Neurology; 1997 May; 48(5):1440-2. PubMed ID: 9153487
[TBL] [Abstract][Full Text] [Related]
8. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin for post-stroke spastic hypertonia: a review of its efficacy and application in clinical practice.
Francisco GE
Ann Acad Med Singap; 2007 Jan; 36(1):22-30. PubMed ID: 17285183
[TBL] [Abstract][Full Text] [Related]
10. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin assessment, intervention and aftercare for cervical dystonia and other causes of hypertonia of the neck: international consensus statement.
Novak I; Campbell L; Boyce M; Fung VS;
Eur J Neurol; 2010 Aug; 17 Suppl 2():94-108. PubMed ID: 20633181
[TBL] [Abstract][Full Text] [Related]
12. Role of motor end plate-targeted Botulinum toxin type A injections in children with cerebral palsyitle.
Van Campenhout A; Bar-On L; Desloovere K; Molenaers G
Acta Orthop Belg; 2015 Jun; 81(2):167-71. PubMed ID: 26280952
[TBL] [Abstract][Full Text] [Related]
13. Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia.
Adler CH; Factor SA; Brin M; Sethi KD
Mov Disord; 2002 Jan; 17(1):158-61. PubMed ID: 11835455
[TBL] [Abstract][Full Text] [Related]
14. Treatment of focal dystonia involving multiple muscles with a single injection of botulinum toxin A to 1 muscle: A case report.
Lee SY; Lee HD; Cho YS; Han SH
Medicine (Baltimore); 2018 Oct; 97(42):e12785. PubMed ID: 30334967
[TBL] [Abstract][Full Text] [Related]
15. Use of mirror dystonia as guidance for injection of botulinum toxin in writing dysfunction.
Singer C; Papapetropoulos S; Vela L
J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1608-9. PubMed ID: 16227568
[No Abstract] [Full Text] [Related]
16. [Clinical profile of persistent generalized muscle contraction following the insult of developing brain].
Maruyama K; Iai M; Arai H; Yokochi K
No To Hattatsu; 2014 Jan; 46(1):10-5. PubMed ID: 24620424
[TBL] [Abstract][Full Text] [Related]
17. An open-label study of botulinum toxin A for treatment of tardive dystonia.
Tarsy D; Kaufman D; Sethi KD; Rivner MH; Molho E; Factor S
Clin Neuropharmacol; 1997 Feb; 20(1):90-3. PubMed ID: 9037579
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Botulinum Toxin A Injections in the Spine Muscles for Cerebral Palsy Scoliosis, Examined in a Prospective, Randomized Triple-blinded Study.
Wong C; Pedersen SA; Kristensen BB; Gosvig K; Sonne-Holm S
Spine (Phila Pa 1976); 2015 Dec; 40(23):E1205-11. PubMed ID: 26165216
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials.
Lew MF; Brashear A; Factor S
Neurology; 2000; 55(12 Suppl 5):S29-35. PubMed ID: 11188982
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin treatment of axial and cervical dystonia.
Benecke R; Dressler D
Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
